Di Michele Joseph, Rotondo Fabio, Kovacs Kalman, Syro Luis V, Yousef George M, Cusimano Michael D, Di Ieva Antonio
Department of Surgery, Division of Neurosurgery and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.
Department of Laboratory Medicine, Division of Pathology and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B1W8, Canada.
Pathol Oncol Res. 2017 Oct;23(4):803-809. doi: 10.1007/s12253-017-0196-4. Epub 2017 Jan 13.
The term "vasculogenic mimicry" (VM) refers to the phenomenon in which vascular-like channels, which are not lined by endothelial cells, are formed in tumors. Since its discovery in 1999, it has been observed in several tumor types and is proposed to provide blood perfusion to tumors in absence of co-apted or neo-angiogenic blood vessels. Pituitary tumors are generally slow growing, benign adenomas which are less vascularized than the normal pituitary gland. To date, VM in pituitary adenomas has not been described. In this histological study, we assessed the presence of VM in a series of surgically resected clinically non-functioning pituitary adenomas (NFPAs) using CD34 and Periodic Acid-Schiff (PAS) double staining. To identify VM, slides were assessed for the presence of CD34-negative and PAS-positive channels indicating that they were not lined by endothelial cells. The histological staining pattern suggestive of VM was noted in 22/49 (44.9%) of the specimens studied. VM was observed in both recurring and non-recurring NFPAs. The incidence of VM present varied from case to case and within groups. There was no association between the presence of VM and gender, tumor size, Ki-67 index, recurrence or cavernous sinus invasion. VM was not noted in cases of non-tumorous pituitaries. Our findings suggest the existence of a complementary perfusion system in pituitary adenomas, implying potential clinical implications with respect to response to therapy and clinical course. Further research is warranted to confirm the presence of VM in pituitary adenomas to elucidate its clinical relevance in patients diagnosed with a pituitary adenoma.
“血管生成拟态”(VM)这一术语指的是肿瘤中形成的并非由内皮细胞衬里的血管样通道的现象。自1999年被发现以来,已在多种肿瘤类型中观察到该现象,并且有人提出它能在缺乏吻合或新生血管的情况下为肿瘤提供血液灌注。垂体瘤通常生长缓慢,是良性腺瘤,其血管化程度低于正常垂体。迄今为止,垂体腺瘤中的血管生成拟态尚未见报道。在这项组织学研究中,我们使用CD34和过碘酸希夫(PAS)双重染色评估了一系列手术切除的临床无功能垂体腺瘤(NFPA)中血管生成拟态的存在情况。为了识别血管生成拟态,对切片进行评估,查看是否存在CD34阴性且PAS阳性的通道,这表明它们没有内皮细胞衬里。在所研究的49个标本中有22个(44.9%)观察到提示血管生成拟态的组织学染色模式。在复发性和非复发性NFPA中均观察到了血管生成拟态。血管生成拟态的发生率因病例不同以及在不同组内而有所差异。血管生成拟态的存在与性别、肿瘤大小、Ki-67指数、复发或海绵窦侵犯之间均无关联。在非肿瘤性垂体病例中未观察到血管生成拟态。我们的研究结果提示垂体腺瘤中存在一种补充性灌注系统,这意味着在治疗反应和临床病程方面可能具有潜在的临床意义。有必要进行进一步研究以证实垂体腺瘤中血管生成拟态的存在,从而阐明其在垂体腺瘤诊断患者中的临床相关性。